USP - Normes de la Pharmacopée des États-Unis

((Z)-N,N-diéthyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidène)méthyl)-2,4-diméthyl-1H-pyrrole-3-carboxamido)éthane-1-amine oxyde)

((Z)-N-(2-(éthylamino)éthyl)-5-((5-fluoro-2-oxoindolin-3-ylidène)méthyl)-2,4-diméthyl-1H-pyrrole-3-carboxamide)

(4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxyméthyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one)

(acétate de méthyle 2-hydroxy-2,2-di(thiophén-2-yl))

(Di-2-thiénylméthanone)

((4-amino-1-[(2R,3R,5S)-2-(hydroxyméthyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one S-oxyde)

(1-[(2R,5S)-2-(hydroxyméthyl)-1,3-oxathiolan-5-yl]pyrimidine-2,4(1H,3H)-dione)

(4-amino-1-[(2RS,5RS)-2-(hydroxyméthyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 1-[(2RS,5RS)-2-(hydroxyméthyl)-1,3-oxathiolan-5-yl]cytosine)

(N-methyl-N-(2-(phenyl(o-tolyl)methoxy)ethyl)nitrous amide)

(N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylnitrous amide)

((R)-N-(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-N-methylnitrous amide)

(N,N-Diphenylnitrosoamine)

(10 mg

(2-((2,3-Dimethylphenyl)(nitroso)amino)benzoic acid)

(N-methyl-N-(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)nitrous amide)

((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-nitrosopiperidine)

((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)méthyl)-4-(4-fluorophényl)-1-nitrosopipéridine)

((R)-N-(2-hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylnitrous amide)

((S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide)

((S)-N-(2-amino-4,5,6,7-tétrahydrobenzo[d]thiazol-6-yl)-N-propylnitreux amide)

(N,N-Bis(2-hydroxyéthyl)nitrosoamines)

(N-Nitroso-(RS)-1-[(RS)-6-fluorochroman-2-yl]-2-({(RS)-2-[(SR)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethan-1-ol)

(5-((3aS,4S,6aR)-1-nitroso-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic Acid)